secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001104659-25-063287
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve amended 2015 Stock Incentive Plan; increase share reserve by 950k shares and extend plan to 2035
--------------------------------------------------------------------------------

- Shareholders approved amendment to 2015 Stock Incentive Plan, increasing share reserve by 950,000 shares to 14,770,000 total.
- Plan expiration extended to April 24, 2035; Lead Independent Director retainer increased by $5,000 per year.
- All 12 director nominees elected; say-on-pay passed with ~95% of votes cast.
- The stock plan amendment passed with ~92% of votes cast; Ernst & Young ratified as auditor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925063287/0001104659-25-063287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465925063287/tm2519194d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-063287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer